These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31403980)

  • 21. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
    Koslowski MJ; Kübler I; Chamaillard M; Schaeffeler E; Reinisch W; Wang G; Beisner J; Teml A; Peyrin-Biroulet L; Winter S; Herrlinger KR; Rutgeerts P; Vermeire S; Cooney R; Fellermann K; Jewell D; Bevins CL; Schwab M; Stange EF; Wehkamp J
    PLoS One; 2009; 4(2):e4496. PubMed ID: 19221600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.
    Wehkamp J; Chu H; Shen B; Feathers RW; Kays RJ; Lee SK; Bevins CL
    FEBS Lett; 2006 Oct; 580(22):5344-50. PubMed ID: 16989824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
    Wehkamp J; Salzman NH; Porter E; Nuding S; Weichenthal M; Petras RE; Shen B; Schaeffeler E; Schwab M; Linzmeier R; Feathers RW; Chu H; Lima H; Fellermann K; Ganz T; Stange EF; Bevins CL
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18129-34. PubMed ID: 16330776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
    Ramasundara M; Leach ST; Lemberg DA; Day AS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.
    Wehkamp J; Harder J; Weichenthal M; Mueller O; Herrlinger KR; Fellermann K; Schroeder JM; Stange EF
    Inflamm Bowel Dis; 2003 Jul; 9(4):215-23. PubMed ID: 12902844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.
    Koslowski MJ; Teltschik Z; Beisner J; Schaeffeler E; Wang G; Kübler I; Gersemann M; Cooney R; Jewell D; Reinisch W; Vermeire S; Rutgeerts P; Schwab M; Stange EF; Wehkamp J
    PLoS Genet; 2012; 8(2):e1002523. PubMed ID: 22393312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms present in IL10, IL23R, NOD2, and ATG16L1 associated with susceptibility to inflammatory bowel disease in Mexican population.
    Quiroz-Cruz S; Posada-Reyes B; Alatorre-García T; Del Real-Calzada CM; García-Samper X; Escobar-Gutiérrez A; Vázquez-Chacón CA; Martínez-Guarneros JA; Cruz-Rivera M; Vaughan G; Fonseca-Coronado S
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):10-16. PubMed ID: 31651650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory bowel disease: an impaired barrier disease.
    Jäger S; Stange EF; Wehkamp J
    Langenbecks Arch Surg; 2013 Jan; 398(1):1-12. PubMed ID: 23160753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.
    Dring MM; Goulding CA; Trimble VI; Keegan D; Ryan AW; Brophy KM; Smyth CM; Keeling PW; O'Donoghue D; O'Sullivan M; O'Morain C; Mahmud N; Wikström AC; Kelleher D; McManus R
    Gastroenterology; 2006 Feb; 130(2):341-8; quiz 592. PubMed ID: 16472590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
    World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations.
    Schnitzler F; Friedrich M; Wolf C; Stallhofer J; Angelberger M; Diegelmann J; Olszak T; Tillack C; Beigel F; Göke B; Glas J; Lohse P; Brand S
    PLoS One; 2015; 10(7):e0116044. PubMed ID: 26147989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease.
    Norén E; Almer S; Söderman J
    BMC Gastroenterol; 2017 May; 17(1):68. PubMed ID: 28545409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key Determinants of Human α-Defensin 5 and 6 for Enhancement of HIV Infectivity.
    Valere K; Lu W; Chang TL
    Viruses; 2017 Aug; 9(9):. PubMed ID: 28850095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn's disease.
    Kübler I; Koslowski MJ; Gersemann M; Fellermann K; Beisner J; Becker S; Rothfuss K; Herrlinger KR; Stange EF; Wehkamp J
    Aliment Pharmacol Ther; 2009 Sep; 30(6):621-33. PubMed ID: 19549264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.